Danaher Corp.
- BID
152.25
- ASK
152.45
- 131 Units131 Units
- 07/21, 16:36:30 PM
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
8.20%
Market Cap
125.03 Bil.
P/E Ratio
45.36
Dividend Yield
0.56 %
Earnings per Share
4.47 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 152.55 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 04:33:38 PM | |
| DAILY VOLUME (UNITS) | 46 | |
| DAILY HIGH / LOW | 176.5 | 146.8 |
| PREV. DAY'S PRICE | 176.65 | (07/20) |
| CHANGE DAY BEFORE | -24.10 | -13.64 % |
| 52 WEEK HIGH / LOW | 208.75 (01/22) | 138.05 (05/18) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 5.90 | 4.89 | 4.47 | 7.39 | 7.95 |
DIVIDENDS PER SHARE | 0.97 | 1.00 | 1.13 | 1.23 | 1.36 |
DIVIDEND YIELD IN % | 0.45 % | 0.47 % | 0.56 % | - | - |
DIVIDEND GROWTH IN % | 2.13 % | 2.80 % | 13.64 % | - | - |
PRICE - EARNINGS RATIO | 36.24 | 43.40 | 45.36 | 24.12 | 22.40 |
PRICE - BOOK RATIO | 3.20 | 3.33 | 3.08 | - | - |
PRICE - SALES RATIO | 7.20 | 7.09 | 6.67 | - | - |
PRICE - CASH FLOW RATIO | 24.00 | 25.30 | 25.55 | - | - |
Master Data
| WKN | 866197 |
| ISIN | US2358511028 |
| SYMBOL | DAP |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Danaher |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | 707.77 Mil. |
| MARKET CAPITALISATION | 125.03 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 0.40 % | 14.78 % | 6.54 % | -11.83 % | 8.20 % | -9.66 % | -16.90 % | -9.40 % |
| HIGH | 179.00 | 179.00 | 179.00 | 208.75 | 208.75 | 259.90 | 262.86 | 208.75 |
| LOW | 171.15 | 152.05 | 138.05 | 138.05 | 138.05 | 138.05 | 138.05 | 138.05 |
Dividende
pro Aktie
Company profile
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
Structured products for Danaher Corp.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.